Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Mezzasoma

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2003
NCX4016: a novel antithrombotic agentP Gresele, S Momi, A M Mezzasoma
Experimental Parasitology|July 27, 2000
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdumS Momi, S Perito, A M Mezzasoma, et al.
Cytometry. Part B, Clinical Cytometry|January 18, 2008
A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometryS Giannini, A M Mezzasoma, G Guglielmini, et al.
Journal of Periodontal Research|August 5, 1998
PAF levels in saliva are regulated by inflammatory cellsE Ribaldi, M Guerra, A M Mezzasoma, et al.
Thrombosis Research|January 14, 2023
High-on-treatment platelet reactivity predicts adverse outcome after carotid artery stenting: A prospective studyG Simonte, G Guglielmini, E Falcinelli, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 1, 1997
Ineffectiveness of a four week treatment with the thromboxane synthetase inhibitor, imidazole salycilate, in reducing airway hyperresponsiveness to methacholine in asthmaticsF Peccini, M L Dottorini, G Casucci, et al.
Thrombosis and Haemostasis|August 9, 2013
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the ruleP Gresele, D De Rocco, L Bury, et al.
British Journal of Pharmacology|July 1, 1996
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activationE Ribaldi, A M Mezzasoma, E Francescangeli, et al.
Biochemical Pharmacology|January 7, 1993
Cloricromene inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipidsP Gresele, E Ribaldi, A M Mezzasoma, et al.
European Journal of Pharmacology|June 14, 2000
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirinS Momi, M Emerson, W Paul, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2003
NCX4016: a novel antithrombotic agentP Gresele, S Momi, A M Mezzasoma
Experimental Parasitology|July 27, 2000
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdumS Momi, S Perito, A M Mezzasoma, et al.
Cytometry. Part B, Clinical Cytometry|January 18, 2008
A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometryS Giannini, A M Mezzasoma, G Guglielmini, et al.
Journal of Periodontal Research|August 5, 1998
PAF levels in saliva are regulated by inflammatory cellsE Ribaldi, M Guerra, A M Mezzasoma, et al.
Thrombosis Research|January 14, 2023
High-on-treatment platelet reactivity predicts adverse outcome after carotid artery stenting: A prospective studyG Simonte, G Guglielmini, E Falcinelli, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 1, 1997
Ineffectiveness of a four week treatment with the thromboxane synthetase inhibitor, imidazole salycilate, in reducing airway hyperresponsiveness to methacholine in asthmaticsF Peccini, M L Dottorini, G Casucci, et al.
Thrombosis and Haemostasis|August 9, 2013
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the ruleP Gresele, D De Rocco, L Bury, et al.
British Journal of Pharmacology|July 1, 1996
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activationE Ribaldi, A M Mezzasoma, E Francescangeli, et al.
Biochemical Pharmacology|January 7, 1993
Cloricromene inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipidsP Gresele, E Ribaldi, A M Mezzasoma, et al.
European Journal of Pharmacology|June 14, 2000
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirinS Momi, M Emerson, W Paul, et al.
Pageof 2